Citations 1
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
Tefferi, Ayalew , Guglielmelli, Paola , Finke, Christy M. , Wassie, Emnet A, Pieri, Lisa , Gangat, Naseema , Fjerza, Rajmonda, Belachew, Alem A. , Ketterling, Rhett P. , Hanson, Curtis A. , Rambaldi, Alessandro , Thiele, Jüergen, Barbui, Tiziano , Pardanani, Animesh , Lasho, Terra L. , Larson, Dirk R. , Finazzi, Guido , Vannucchi, Alessandro M. , Rambaldi, Alessandro , Ketterling, Rhett P , Guglielmelli, Paola
Blood | July 18, 2014 | Volume: 124 | Issue: 16 | Pages: 2507-2513
Key Points Survival in ET is superior to that of PV, regardless of mutational status, but remains inferior to the sex- and age-matched US population. JAK2/CALR/MPL mutational status is prognostically informative in PMF, regarding overall and leukemia-free survival.